Earlier this year, TrialSite reported on a novel cancer drug known as EXO-CD24 under development at Tel Aviv Sourasky Medical Center (Ichilov Hospital) that demonstrated compelling…
A recent study led by Tel Aviv University and Clatit, Israel’s second largest healthcare provider, found that the South African variant of SARS-CoV-2, known as B.1.351,…
Brazilian officials arrived in Israel to meet with government counterparts to discuss novel ways to overcome the COVID-19 pandemic. On the radar: the Israeli-developed nasal…
Article 1BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy:The British Ivermectin Recommendation Development (BIRD) panel included dozens of multinational scientists and doctors discussing the mounting…
Recently, Professor Eli Schwarz, the Director of the Center for Geographic Medicine at Sheba Medical Center in Tel-Hashomer, Israel, reported on the success of a randomly controlled,…
Since the start of February, various press have reported that the people of Israel are the most vaccinated in the word by a large margin…
Israel’s Ministry of Health (MOH) approved the compassionate use of an investigational drug for patients with Leukocyte Adhesion Deficiency Type II (LAD-II). Orpha Labs AG…
Recently, Sheba Medical Center based in Ramat Gan, Israel, shared some promising observations associated with the Pfizer/BioNTech COVID-19 vaccine. To date, over 7,000 employees have…
While the U.S., U.K. and Europe attempt to ramp up their own Covid vaccination drives, one country is outpacing them all: Israel. Israel’s vaccination drive…
Yehonatan Medical, an Israeli startup, is working tirelessly to help resolve the shortage of ventilators in that country’s COVID-19 intensive care units. A revolutionary type…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
